What were Lupin Ltd's latest quarterly results?
Lupin Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +87.9% (stable)
- Revenue Growth YoY: +31.9%
- Operating Margin: 33.0% (volatile)
Lupin Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +10.8%Strong12w Streak
In , Lupin Ltd (Pharma - Formulators) is outperforming Nifty 500 with +10.8% relative strength. Fundamentals: Strong. On a 12-week streak.
Lupin Ltd Key Facts
- PE Ratio
- 18.9x
- Price/Book
- 5.06x
- Market Cap
- ₹1,08,795 Cr
- PAT Growth YoY
- +88%
- Revenue Growth YoY
- +32%
- OPM
- 33.0%
- RS vs Nifty 500
- +10.8%
PE: Cycle BottomStrong Opportunity
What's Happening
💎PE falling while earnings hold — value emerging
🌐FII stake decreased 1.0% this quarter
🏛️DII accumulation — stake up 1.5%
💰Trading 143% below estimated fair value — significant discount
Key Numbers
PAT Growth YoY
+88%
Stable
Revenue YoY
+32%
Accelerating
Operating Margin
33.0%
+1000 bps YoY
PE Ratio
18.9
PEG Ratio
0.80
EV/EBITDA
15.5
Current Price
₹2,380
Dividend Yield
0.50%
Fundamental Score
75/100
Strong
3Y PAT CAGR
+80%
Market Cap
1.1L Cr
Valuation
Significantly Undervalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is Lupin Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +32% | +19% | Accelerating |
| PAT (Net Profit) | +88% | +80% | Stable |
| OPM | 33.0% | +1000 bps | Volatile |
Other Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: Lupin Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is Lupin Ltd's profit growing or declining?
Lupin Ltd's profit is growing with an stable trend.
- PAT Growth YoY: +87.9% (latest quarter)
- PAT Growth QoQ: +24.4% (sequential)
- 3-Year PAT CAGR: +80.0%
- Trend: Stable — consistent growth pattern
What is Lupin Ltd's revenue growth trend?
Lupin Ltd's revenue growth trend is accelerating.
- Revenue Growth YoY: +31.9%
- Revenue Growth QoQ: +4.3% (sequential)
- 3-Year Revenue CAGR: +18.9%
How is Lupin Ltd's operating margin trending?
Lupin Ltd's operating margin is volatile.
- Current OPM: 33.0%
- OPM Change YoY: +10.0% basis points
- OPM Change QoQ: +1.0% basis points
What is Lupin Ltd's 3-year profit and revenue CAGR?
Lupin Ltd's long-term compounding rates
- 3-Year Profit CAGR: +80.0%
- 3-Year Revenue CAGR: +18.9%
Is Lupin Ltd's growth accelerating or decelerating?
Lupin Ltd's earnings growth is stable with mixed signals on a sequential basis.
- YoY Acceleration: +50.4% bps
- Sequential Acceleration: +44.9% bps
What is Lupin Ltd's trailing twelve month (TTM) performance?
Lupin Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹5,000 Cr
- TTM PAT Growth: +62.0% YoY
- TTM Revenue: ₹28,000 Cr
- TTM Revenue Growth: +23.1% YoY
- TTM Operating Margin: 31.6%
Is Lupin Ltd overvalued or undervalued?
Lupin Ltd appears significantly undervalued based on our fair value analysis.
- Valuation Signal: Significantly Undervalued
- Current PE: 18.9x
- Price-to-Book: 4.8x
What is Lupin Ltd's current PE ratio?
Lupin Ltd's current PE ratio is 18.9x.
- Current PE: 18.9x
- Market Cap: 1.1 Lakh Cr
- Dividend Yield: 0.50%
How does Lupin Ltd's valuation compare to its history?
Lupin Ltd's current PE is 18.9x.
- Current PE: 18.9x
- Valuation Assessment: Significantly Undervalued
What is Lupin Ltd's price-to-book ratio?
Lupin Ltd's price-to-book ratio is 4.8x.
- Price-to-Book (P/B): 4.8x
- Book Value per Share: ₹491
- Current Price: ₹2380
Is Lupin Ltd a fundamentally strong company?
Lupin Ltd is rated Strong with a fundamental score of 74.57/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +31.9% (10% weight)
- PAT Growth YoY: +87.9% (10% weight)
- PAT Growth QoQ: +24.4% (10% weight)
- Margins stable (10% weight)
- PEG Ratio: 0.8x vs sector median (15% weight)
- EV/EBITDA: 15.5x vs sector median (15% weight)
Is Lupin Ltd debt free?
Lupin Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹7,000 Cr
What is Lupin Ltd's return on equity (ROE) and ROCE?
Lupin Ltd's return ratios over recent years
- FY2024: ROCE 16.0%
- FY2025: ROCE 21.0%
- FY2026: ROCE 30.0%
Is Lupin Ltd's cash flow positive?
Lupin Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹7,000 Cr
- Free Cash Flow (FCF): ₹3,000 Cr
- CFO/PAT Ratio: 137% (strong cash conversion)
What is Lupin Ltd's dividend yield?
Lupin Ltd's current dividend yield is 0.50%.
- Dividend Yield: 0.50%
- Current Price: ₹2380
Who holds Lupin Ltd shares — promoters, FII, DII?
Lupin Ltd's shareholding pattern (Mar 2026)
- Promoters: 46.9%
- FII (Foreign): 21.7%
- DII (Domestic): 25.3%
- Public: 6.1%
Is promoter holding increasing or decreasing in Lupin Ltd?
Lupin Ltd's promoter holding has decreased recently.
- Current Promoter Holding: 46.9% (Mar 2026)
- Previous Quarter: 46.9% (Dec 2025)
- Change: -0.04% (decreasing — worth monitoring)
How long has Lupin Ltd been outperforming Nifty 500?
Lupin Ltd has been outperforming Nifty 500 for 12 consecutive weeks, indicating strong sustained outperformance.
Is Lupin Ltd a new momentum entry or an established outperformer?
Lupin Ltd is an established outperformer with 12 weeks of consecutive Nifty 500 outperformance.
Is Lupin Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Lupin Ltd may be worth studying
- Earnings growing at +87.9% YoY
- Revenue growth is accelerating — +31.9% YoY
- Valuation: appears significantly undervalued
- Cash flow is positive — CFO ₹7,000 Cr
What is the investment thesis for Lupin Ltd?
Lupin Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +31.9% YoY
- Appears significantly undervalued
What is the future outlook for Lupin Ltd?
Lupin Ltd's forward outlook based on current data signals
- Earnings Trend: stable
- Revenue Trend: accelerating
- Margin Trend: volatile
- Valuation: Significantly Undervalued
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.